Drug profile · INN
paramethadione
PARADIONE
paramethadione (PARADIONE) is a voltage-gated t-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — paramethadione
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
paramethadione (PARADIONE) is a voltage-gated t-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated T-type calcium channel blocker
Primary target: Voltage-gated T-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is paramethadione?
paramethadione (PARADIONE) is a voltage-gated t-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for paramethadione?
PARADIONE is a marketed brand name for paramethadione. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of paramethadione?
paramethadione has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.